“We have to have an open and honest discussion about whether the guard rails are really appropriate for a country like Germany, because we’ve seen innovative products opting out from Germany and this is not the way to go.” – EUCOPE’s Alexander Natz discusses a new German law and flaws in the country’s pricing system. Find out more: New German Research Law Fails To Stop Companies From Opting Out Of The Market
Quotable: Top Experts On Policy Hot Topics
The Pink Sheet highlights recent comments and insights from pharma officials and executives on key issues we are covering.
